Yahoo · Oct 23, 2026
McKesson's Quarterly Earnings Preview: What You Need to Know
McKesson will release its second-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

NYSE · MCK
Healthcare · Medical - Distribution
$980.88
Up+$13.70 (+1.40%)
Updated Oct 30, 2026, 10:51 PM
SID Score
6.9/10
Composite research score
Smart Money
57/100
Neutral
Price performance · MCK
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
MCK closed at $980.88 after 21 trading sessions, up 9.13% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $975.00 | $982.70 | $964.77 | $980.88 | 721.49K |
| Oct 28, 2026 | $955.95 | $970.925 | $954.05 | $960.56 | 764.14K |
| Oct 27, 2026 | $989.04 | $992.8225 | $966.49 | $967.02 | 587.07K |
| Oct 26, 2026 | $1,001.39 | $1,008.60 | $988.03 | $992.87 | 508.22K |
| Oct 23, 2026 | $1,010.32 | $1,012.495 | $997.02 | $1,000.77 | 628.97K |
| Oct 22, 2026 | $1,025.62 | $1,025.62 | $1,006.07 | $1,012.34 | 629.49K |
| Oct 21, 2026 | $1,020.93 | $1,030.00 | $1,005.42 | $1,015.50 | 772.09K |
| Oct 20, 2026 | $1,021.14 | $1,030.27 | $1,013.925 | $1,030.12 | 789.41K |
| Oct 19, 2026 | $995.72 | $1,012.58 | $977.8888 | $1,010.43 | 757.17K |
| Oct 16, 2026 | $1,012.20 | $1,014.99 | $999.27 | $1,004.84 | 621.36K |
| Oct 15, 2026 | $995.80 | $1,003.21 | $988.61 | $998.64 | 728.67K |
| Oct 14, 2026 | $968.07 | $979.82 | $965.045 | $976.57 | 769.08K |
| Oct 13, 2026 | $963.42 | $969.477 | $954.18 | $961.88 | 743.64K |
| Oct 12, 2026 | $949.95 | $956.24 | $936.7742 | $955.76 | 646.98K |
| Oct 9, 2026 | $927.56 | $943.97 | $925.00 | $938.84 | 482.91K |
| Oct 8, 2026 | $906.65 | $938.51 | $906.65 | $930.25 | 715.66K |
| Oct 7, 2026 | $924.21 | $933.99 | $908.49 | $910.33 | 794.46K |
| Oct 6, 2026 | $921.00 | $928.46 | $914.225 | $921.67 | 680.46K |
| Oct 5, 2026 | $905.22 | $922.46 | $900.72 | $915.45 | 697.63K |
| Oct 2, 2026 | $899.02 | $905.55 | $881.40 | $902.28 | 777.05K |
| Oct 1, 2026 | $886.47 | $924.21 | $881.34 | $898.82 | 1.21M |
The latest Smart Investors Daily articles mentioning MCK.
Company
Market Activity
Research & News
MCK research
Company profile and research snapshot.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 20, 2026 | Mizuho | Neutral | — |
| Oct 16, 2026 | UBS | Buy | — |
| Oct 7, 2026 | Leerink Partners | Outperform | — |
| Sep 14, 2026 | RBC Capital | Sector Perform | — |
| Aug 19, 2026 | Barclays | Overweight | — |
No generated briefing is available yet.
Yahoo · Oct 23, 2026
McKesson will release its second-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.
Yahoo · Oct 21, 2026
The latest trading day saw McKesson (MCK) settling at $1, representing a -1.42% change from its previous close.
Yahoo · Oct 21, 2026
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Yahoo · Oct 21, 2026
IRVING, Texas, October 21, 2026--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 94 cents per share of common stock. The dividend will be payable on January 4, 2027, to shareholders of record on December 1, 2026.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning MCK.